4//SEC Filing
Bratica Joseph 4
Accession 0001209191-20-063355
CIK 0000873303other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:00 PM ET
Size
8.9 KB
Accession
0001209191-20-063355
Insider Transaction Report
Form 4
Bratica Joseph
Principal Financial Officer
Transactions
- Sale
Common Stock
2020-12-11$165.00/sh−1,115$183,975→ 8,140 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-11−1,115→ 12,285 totalExercise: $71.45From: 2019-03-05Exp: 2028-03-05→ Common Stock (1,115 underlying) - Exercise/Conversion
Common Stock
2020-12-11$71.45/sh+1,115$79,667→ 9,255 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001820070
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 8:00 PM ET
- Size
- 8.9 KB